A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants

NCT03933488 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: TAK-994
DRUG: TAK-994 Placebo

Sponsor

Takeda